The Medicines and Healthcare products Regulatory Agency (MHRA) published its latest compilation of field safety notices (FSNs) for the week of 6–10 April 2026, covering medical devices and equipment used across healthcare settings in the United Kingdom.
While field safety notices primarily concern medical devices rather than medicines, community pharmacies increasingly interact with device-adjacent products — from blood glucose monitors and blood pressure cuffs to diagnostic testing kits used in Pharmacy First consultations. Understanding the FSN system is part of professional practice.
What are field safety notices?
Field safety notices are issued by manufacturers of medical devices when a product has a safety issue that requires corrective action. The MHRA collates and publishes these weekly as part of its post-market surveillance role under the Medical Devices Regulations 2002 and subsequent amendments.
FSNs can cover anything from software updates for hospital imaging equipment to recalls of consumer-facing devices such as thermometers, pulse oximeters, or lateral flow test kits. Community pharmacies are most likely to encounter FSNs relating to:
- Point-of-care testing devices used in Pharmacy First and blood pressure checking services
- Blood glucose monitors and test strips sold over the counter or supplied on prescription
- Nebulisers and respiratory devices that pharmacies may sell or advise on
- Sharps containers and drug delivery devices such as insulin pens
Why pharmacies should monitor FSNs
The General Pharmaceutical Council's (GPhC) standards for registered pharmacies include maintaining awareness of safety alerts relevant to products supplied or services provided. While pharmacies are not required to act on every FSN — many concern hospital-grade equipment — those that operate clinical services have a professional obligation to check whether any recalled devices are in use.
For pharmacies providing NHS blood pressure checking services, Pharmacy First consultations using diagnostic equipment, or flu and COVID-19 vaccination programmes, FSNs may directly affect the devices used in patient-facing care.
How to stay informed
The MHRA publishes FSN compilations weekly on GOV.UK. Pharmacies can:
- Subscribe to MHRA email alerts at gov.uk/drug-device-alerts to receive notifications when new FSNs are published
- Check weekly compilations every Monday for the previous week's notices
- Cross-reference any devices used in pharmacy services against the current FSN list
- Document checks as part of standard operating procedures, particularly for pharmacies accredited to provide enhanced services
The distinction between field safety notices (devices) and drug safety updates (medicines) is important. Medicine recalls and alerts are published separately through the MHRA's drug safety update and Class 2 and Class 3 medicine recall channels.
Context: pharmacy's expanding clinical role
The relevance of FSNs to community pharmacy has grown as the sector takes on more clinical services. Since the launch of Pharmacy First in January 2024, community pharmacies across England have been conducting clinical assessments that may involve diagnostic equipment. According to PharmSee's analysis of 1,665 active pharmacy vacancies, many roles now specify clinical service delivery as a core responsibility.
As the scope of community pharmacy practice widens, so does the range of devices and equipment that pharmacies need to monitor for safety alerts.
For pharmacists and pharmacy technicians looking for roles that involve clinical services, PharmSee's job search tracks vacancies across 11 employer sources, and salary data shows what clinical roles currently pay.
Sources: MHRA Field Safety Notices 6–10 April 2026; GPhC Standards for Registered Pharmacies; PharmSee vacancy data (April 2026).